Journal of Cardiothoracic Surgery (Oct 2022)

Thymic adenocarcinoma presenting as an incidental mediastinal mass

  • Anne E. O’Shea,
  • Alexander P. Nissen,
  • Donnell K. Bowen,
  • Taylor L. Barnett,
  • Joshua D. Gustafson

DOI
https://doi.org/10.1186/s13019-022-02000-8
Journal volume & issue
Vol. 17, no. 1
pp. 1 – 4

Abstract

Read online

Abstract Background Primary thymic adenocarcinoma represents an exceptionally rare malignancy, for which the cornerstone of therapy is margin-negative resection, with radiation and systemic therapy reserved for invasive and advanced disease. Thymic adenocarcinoma has not been previously reported in the setting of a concomitant malignancy, as reported herein. Case presentation We present a case of a 55-year-old previously healthy male diagnosed with acute myeloid leukemia, also found to have a mediastinal mass. Evaluation of the mediastinal mass with tumor markers, biopsies, and next-generation sequencing proved non-diagnostic, while he was simultaneously treated with induction chemotherapy to prevent leukemia-related blast crisis. After completing and recovering from induction chemotherapy, he underwent successful thymectomy during a chemotherapy holiday, with a margin-negative resection of thymic adenocarcinoma. He has subsequently recovered and undergone successful allogeneic hematopoietic stem cell transplant. Conclusions We present a case of synchronous adult acute myeloid leukemia and primary thymic adenocarcinoma requiring a tailored approach for management of simultaneous malignancies.

Keywords